SCHEMBL21679508

SCHEMBL21679508

COc1ccc2cc(C(=O)/C=C/c3ccc(C)cc3)ccc2c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.78
MAOA P21397 3/20 0.78
F3 P13726 2/20 0.68
NPC1 O15118 3/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
ABCG2 Q9UNQ0 4/20 0.65
TNFRSF1A P19438 1/20 0.64
MAPT P10636 5/20 0.64
CYP1A1 P04798 1/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
CYP1B1 Q16678 1/20 0.63
XDH P47989 2/20 0.61
RAB9A P51151 2/20 0.61
P4HB P07237 1/20 0.61
CALM1 P0DP23 1/20 0.61
ALDH1A1 P00352 1/20 0.61
LMNA P02545 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21679509 1.00 MAOB (0.78) MAOBMAOAF3NPC1MEN1
SCHEMBL29869351 1.00 MAOB (0.78) MAOBMAOAF3NPC1MEN1
SCHEMBL14044966 0.88 MAOB (1.00) MAOBMAOAF3NPC1MEN1
SCHEMBL14307274 0.88 MAOB (1.00) MAOBMAOAF3NPC1MEN1
SCHEMBL9337905 0.88 MAOB (1.00) MAOBMAOAF3NPC1MEN1
SCHEMBL657322 0.87 MEN1 (0.78) MAOBF3NPC1MEN1KMT2A
SCHEMBL657323 0.87 MEN1 (0.78) MAOBF3NPC1MEN1KMT2A
SCHEMBL9341818 0.86 ABCG2 (0.89) MAOBMAOAF3NPC1MEN1
SCHEMBL15631514 0.86 ABCG2 (0.89) MAOBMAOAF3NPC1MEN1
SCHEMBL5888213 0.86 CYP1B1 (0.73) MAOBMAOAF3NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME LBR, LMTK2, MMS19 MAOB 4339/4885MAOA 4331/4885F3 4032/4885
US-11142495-B2 Composition and method for manufacturing device using same LBR, LMTK2, MMS19 MAOB 4339/4885MAOA 4331/4885F3 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.